Global Specialty Generics Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2020 – 2030

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Specialty Generics Market Year-on-Year Growth, 2021 - 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Specialty Generics Market by Route of Administration: Market Size and Forecast, 2020 – 2030

4.1    Overview

4.2  Oral

4.2.1  Current Trend and Analysis

4.2.2  Market Size and Forecast, 2020 - 2030 ($ Billion)

4.2.3  Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

4.3  Injectables

4.3.1  Current Trend and Analysis

4.3.2  Market Size and Forecast, 2020 - 2030 ($ Billion)

4.3.3  Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

4.4  Others

4.4.1  Current Trend and Analysis

4.4.2  Market Size and Forecast, 2020 - 2030 ($ Billion)

4.4.3  Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 5        Global Specialty Generics Market by Disease indication: Market Size and Forecast, 2020 – 2030

5.1  Overview

5.2  Autoimmune Diseases

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

5.3  Oncology

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

5.4  Infectious Diseases

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

5.5  Others

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 6        Global Specialty Generics Market by Distribution Channel: Market Size and Forecast, 2020 – 2030

6.1  Overview

6.2  Specialty Pharmacies

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.3  Retail Pharmacies

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.4  Hospital Pharmaices

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

6.5  Others

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

6.5.3   Market Size and Forecast by Region, 2020 - 2030 ($ Billion)

Chapter 7        Global Specialty Generics Market by Geography: Market Size and Forecast, 2020 – 2030   

7.1  Overview

7.1.1   Global Specialty Generics Market Year-on-Year Growth, by region 2021 – 2030 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.3.2        By Route of Administration

7.2.3.3        By Disease Indication

7.2.3.4        By Distribution Channel

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.4.2        By Route of Administration

7.2.4.3        By Disease Indication

7.2.4.4        By Distribution Channel

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.5.2        By Route of Administration

7.2.5.3        By Disease Indication

7.2.5.4        By Distribution Channel

7.2.6   Rest of North America

7.2.6.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.2.6.2        By Route of Administration

7.2.6.3        By Disease Indication

7.2.6.4        By Distribution Channel

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.3.2        By Route of Administration

7.3.3.3        By Disease Indication

7.3.3.4        By Distribution Channel

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.4.2        By Route of Administration

7.3.4.3        By Disease Indication

7.3.4.4        By Distribution Channel

7.3.5   France

7.3.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.5.2        By Route of Administration

7.3.5.3        By Disease Indication

7.3.5.4        By Distribution Channel

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.6.2        By Route of Administration

7.3.6.3        By Disease Indication

7.3.6.4        By Distribution Channel

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.7.2        By Route of Administration

7.3.7.3        By Disease Indication

7.3.7.4        By Distribution Channel

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.3.8.2        By Route of Administration

7.3.8.3        By Disease Indication

7.3.8.4        By Distribution Channel

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.3.2        By Route of Administration

7.4.3.3        By Disease Indication

7.4.3.4        By Distribution Channel

7.4.4   India

7.4.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.4.2        By Route of Administration

7.4.4.3        By Disease Indication

7.4.4.4        By Distribution Channel

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.5.2        By Route of Administration

7.4.5.3        By Disease Indication

7.4.5.4        By Distribution Channel

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.4.6.2        By Route of Administration

7.4.6.3        By Disease Indication

7.4.6.4        By Distribution Channel

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.3.2        By Route of Administration

7.5.3.3        By Disease Indication

7.5.3.4        By Distribution Channel

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.4.2        By Route of Administration

7.5.4.3        By Disease Indication

7.5.4.4        By Distribution Channel

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2020 - 2030 ($ Billion)

7.5.5.2        By Route of Administration

7.5.5.3        By Disease Indication

7.5.5.4        By Distribution Channel

Chapter 8        Company Profiles

8.1  Novartis

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Akorn Inc.

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Turing Pharmaceuticals

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Mylan N.V.

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  Mallinckrodt plc

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Apotex

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Sun Pharmaceutical Industries Ltd.

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Valeant Pharmaceuticals International Inc.

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Pfizer Inc.

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10       Teva Pharmaceutical Industries Ltd.

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments